Hard drive manufacturer Western Digital has announced the first 1 terabyte capacity SD card at Photokina 2016.
Western Digital Corporation (WDC), which acquired SanDisk for US$19 billion in May, has unveiled a 1 terabyte (TB) SDXC card prototype at the world's leading trade fair for photo and video professionals. With ever-increasing demand for high resolution content, such as 4K and 8K, the company continues to push the boundaries of technology and to demonstrate the power of exponential growth. "Showcasing the most advanced imaging technologies is truly exciting for us," said Dinesh Bahal, Vice President of Product Management. "16 years ago we introduced the first SanDisk 64MB SD card and today we are enabling capacities of 1TB. Over the years, our goal has remained the same: continue to innovate and set the pace for the imaging industry. The SanDisk 1TB SD card prototype represents another significant achievement as growth of high-resolution content and capacity-intensive applications such as virtual reality, video surveillance and 360 video, are progressing at astounding rates." Since the introduction of a record-breaking 512GB memory card at Photokina 2014, Western Digital has proven it can nearly double the capacity in the same SD card form factor using proprietary technology. Higher capacity cards expand the possibilities...
World's first 1 terabyte SD card is announced
Google and GSK invest £540M to create bioelectronic medicines
An early prototype concept for a smart contact lens. This wearable tech would measure glucose levels in tears, using a tiny wireless chip and miniaturised sensor embedded between layers of soft contact lens material. When glucose levels fall below a certain threshold, tiny LED lights will activate themselves to function as a warning system for the wearer. Credit: Google
Google's Verily (formerly Google Life Sciences) has announced a partnership with British pharmaceutical giant, GlaxoSmithKline (GSK), to form Galvani Bioelectronics – a new company focused on the research, development and commercialisation of bioelectronic medicines. Verily (owned by Google's parent company, Alphabet) has announced an agreement with GSK to form Galvani Bioelectronics to accelerate the research, development and commercialisation of bioelectronic medicines. GSK will hold a 55% interest in the new jointly owned company and Verily will hold 45%. Galvani Bioelectronics will be headquartered in the UK, with the parent companies contributing existing intellectual property rights and up to £540 million of investment over seven years, subject to successful completion of various discovery and development milestones. Bioelectronic medicine is a relatively new scientific field that aims to tackle a wide range of chronic diseases using miniaturised, implantable...
Subscribe to:
Posts (Atom)